Argus Research analyst John Staszak downgrades Sysco (NYSE:SYY) from Buy to Hold.
Horizon Therapeutics Responds To U.S. Federal Trade Commission Action To Block Acquisition By Amgen
Horizon Therapeutics plc (NASDAQ:HZNP) today issued the following statement in response to the FTC's complaint seeking to block Amgen's proposed acquisition of the Company:
"This acquisition has the